Frank H Laukien

PRESIDENT & CEO

Frank H Laukien (PRESIDENT & CEO) filed 3 Form 4 reports in the past 24 months (3 purchases, 0 sales), most often in Bruker Corporation (BRKR). Across 3 priced purchase filings, the average 21-session return was +5.6% from execution and +5.1% from disclosure (delay-adjusted; derived). The largest single filing was $5.0M of BRKR (100,000 sh across 3 lots, as filed), executed Nov 18 2024.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

+5.6%

avg across 3 priced filings

Delay-adjustediThe same average, entered at disclosure dates

+5.1%

same 3 filings, from disclosure

Filings, ttm

3 buys · 0 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$6.1M

shares × price, as filed

Last traded

Jun 6 2025

Filed Jun 9 2025

Median ADV $141.1M across their filed names

Open performance→

Volume by month

Buys $6.1M Sells $0

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 3 filings

Sector per market data · by filing · past 24 months

Most traded names

BRKR

Bruker Corporation BRKR · 3 buys · 0 sells 3 filings

Recent filings

BRKRPURCHASE Bruker Corporation View filing → $100K
2,608 sh × $38.36
Exec Jun 6 2025
Filed Jun 9 2025 · 5:30 PM ET BRKRPURCHASE Bruker Corporation View filing → $1.0M
20,000 sh across 2 lots
Exec Feb 18 2025
Filed Feb 19 2025 · 5:30 PM ET BRKRPURCHASE Bruker Corporation View filing → $5.0M
100,000 sh across 3 lots
Exec Nov 18 2024
Filed Nov 19 2024 · 5:30 PM ET